Ontology highlight
ABSTRACT:
SUBMITTER: Norris K
PROVIDER: S-EPMC6756045 | biostudies-literature | 2019 Aug
REPOSITORIES: biostudies-literature
Norris Kevin K Hillmen Peter P Rawstron Andrew A Hills Robert R Baird Duncan M DM Fegan Christopher D CD Pepper Chris C
Leukemia 20190130 8
We have previously shown that dividing patients with CLL into those with telomeres inside the fusogenic range (TL-IFR) and outside the fusogenic range (TL-OFR) is powerful prognostic tool. Here, we used a high-throughput version of the assay (HT-STELA) to establish whether telomere length could predict for outcome to fludarabine, cyclophosphamide, rituximab (FCR)-based treatment using samples collected from two concurrent phase II studies, ARCTIC and ADMIRE (n = 260). In univariate analysis, pat ...[more]